DEVELOPMENT AND EVALUATION OF NOVEL REPAGLINIDE BIO STRIPS FOR TRANSLAB IAL DELIVERY
暂无分享,去创建一个
[1] Yong Wang,et al. Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment. , 2004, Biomaterials.
[2] N. Nafee,et al. Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. , 2003, Acta pharmaceutica.
[3] S. Saisivam,et al. Design and Evaluation of Matrix Diffusion Controlled Transdermal Patches of Verapamil Hydrochloride , 2003, Drug development and industrial pharmacy.
[4] H. Lebovitz,et al. Repaglinide versus glyburide: a one-year comparison trial. , 1999, Diabetes research and clinical practice.
[5] T. Redelmeier,et al. Skin Barrier: Principles of Percutaneous Absorption , 1996 .
[6] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[7] D. Coomans,et al. Development and Testing of Bioadhesive, Fluoride‐containing Slow‐release Tablets for Oral Use , 1991, The Journal of pharmacy and pharmacology.
[8] Brian W. Barry,et al. Dermatological Formulations: Percutaneous Absorption , 1983 .
[9] John H. Draize,et al. METHODS FOR THE STUDY OF IRRITATION AND TOXICITY OF SUBSTANCES APPLIED TOPICALLY TO THE SKIN AND MUCOUS MEMBRANES , 1944 .
[10] Y. Vishnu,et al. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization. , 2007, Current drug delivery.
[11] Susan Budavari,et al. The Merck index , 1998 .
[12] P. Diwan,et al. INFLUENCE OF CASTING SOLVENT ON THE PERMEABILITY OF ETHYL CELLULOSE FREE FILMS FOR TRANSDERMAL USE , 1997 .